Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Expands By 92.3%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 877 shares, an increase of 92.3% from the July 15th total of 456 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 1,618 shares, the days-to-cover ratio is currently 0.5 days.

Innovator IBD Breakout Opportunities ETF Trading Down 0.0%

Shares of BOUT stock traded down $0.02 during trading on Friday, hitting $44.70. The company’s stock had a trading volume of 1,541 shares, compared to its average volume of 3,891. The company has a market cap of $15.65 million, a PE ratio of 28.69 and a beta of 1.04. The business has a fifty day moving average of $46.85 and a 200-day moving average of $43.74. Innovator IBD Breakout Opportunities ETF has a 52 week low of $35.05 and a 52 week high of $49.41.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Osaic Holdings Inc. lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC raised its stake in Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after buying an additional 12,859 shares during the last quarter. Finally, Susquehanna International Group LLP boosted its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after acquiring an additional 7,817 shares in the last quarter.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.